Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |